L1CAM in cancer promotes motility and invasiveness, supporting aggressive tumor growth, metastasis and chemoresistance and in many human cancers, such as ovarian and endometrial carcinoma, frequently correlates to poor prognosis and advanced tumor stage [13]. This evidence concerns the gene L1CAM and neoplasm.